Kidney Management Guidelines for Methylmalonic Acidemia
Author Information
Author(s): Servais Aude, Zacchia Miriam, Dehoux Laurène, Shroff Rukshana, Brassier Anais, Taurisano Roberta, Kölker Stefan, Oh Jun, Ariceta Gema, Stojanovic Jelena, Hörster Friederike, Strologo Dello, Spada Marco, Schiff Manuel, Dionisi-Vici Carlo
Primary Institution: Nephrology and Transplantation Department, Inherited Kidney Diseases Reference Center, Necker-Enfants Malades University Hospital, Assistance Publique Hôpitaux de Paris, Inserm U1163, Imagine Institute, Université de Paris, Paris, France
Hypothesis
The guidelines aim to provide clinical practice recommendations for kidney management in patients with methylmalonic acidemia (MMA).
Conclusion
The guidelines produced 13 statements to guide the management of chronic kidney disease, dialysis, and transplantation in patients with MMA.
Supporting Evidence
- Chronic kidney disease is a common complication in patients with methylmalonic acidemia.
- Creatinine-based formulas overestimate kidney function in these patients.
- Long-term dialysis may be necessary for clearance of toxic metabolites.
Takeaway
Doctors created a set of rules to help treat kids and adults with a rare disease that affects their kidneys. These rules will help them manage kidney problems better.
Methodology
The guidelines were developed through a systematic literature review and expert consensus involving pediatric and adult nephrologists, metabolic specialists, and transplant surgeons.
Potential Biases
Potential bias may arise from the expert panel's perspectives and the selection of literature reviewed.
Limitations
The recommendations are based on expert opinion and existing literature, which may not cover all aspects of patient care.
Participant Demographics
The guidelines consider both pediatric and adult patients with methylmalonic acidemia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website